{"nctId":"NCT00770913","briefTitle":"Double-blind Comparative Study of E3810 Tablets (10 or 20 mg b.i.d.) to Evaluate Efficacy and Safety in Patients With Refractory Reflux Esophagitis","startDateStruct":{"date":"2008-10"},"conditions":["Refractory Reflux Esophagitis"],"count":337,"armGroups":[{"label":"1","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: E3810"]},{"label":"2","type":"EXPERIMENTAL","interventionNames":["Drug: E3810"]},{"label":"3","type":"EXPERIMENTAL","interventionNames":["Drug: E3810"]}],"interventions":[{"name":"E3810","otherNames":["Aciphex"]},{"name":"E3810","otherNames":["Aciphex"]},{"name":"E3810","otherNames":["Aciphex"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Patients who have mucosal breaks (erosions, ulcers) on endoscopy and are diagnosed with reflux esophagitis.\n* Proton Pump Inhibitor standard dose-resistant reflux esophagitis.\n* Patients who are 20 years and older when informed consent is obtained.\n\nExclusion Criteria:\n\n* Patients with a concurrent severe illness, serious heart disease, comorbid severe disease such as hematology, kidney disease, or liver disease.\n* Patients with malignancy.\n* Patients who are taking another trial drug or the interval between the end of treatment and screening is less than 12 weeks.","healthyVolunteers":false,"sex":"ALL","minimumAge":"20 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Percentage of Participants With Healing Demonstrated Via Upper Gastrointestinal Endoscopy (Modified Los Angeles Classification: Grade N)","description":"Grade N indicates a normal appearance of lower esophageal mucosa","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"58.8","spread":null},{"groupId":"OG001","value":"78.4","spread":null},{"groupId":"OG002","value":"77.0","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":3,"n":112},"commonTop":["Nasopharyngitis","Blood thyroid stimulating hormone increased","Constipation","Upper respiratory tract inflammation","Diarrhoea"]}}}